false
Catalog
The Liver Meeting 2019
Precision Medicine and Patients at Risk for Drug-i ...
Precision Medicine and Patients at Risk for Drug-induced Liver Injury*
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In the video, a clinician presents a complex case of a 56-year-old man with unexplained liver injury following antibiotic treatment. The discussion emphasizes the challenges in diagnosing idiosyncratic drug-induced liver injury (DILI) and the limitations of current genetic testing in predicting and preventing these adverse reactions. The clinician explores the role of precision medicine in understanding DILI, highlighting the need for more reliable biomarkers and individualized approaches to treatment and prognosis. Emphasis is placed on ongoing research efforts to improve diagnostic tools and enhance patient outcomes in the context of DILI. The video concludes with a call for further studies to advance the application of precision medicine in the management of DILI.
Asset Caption
Presenter: Robert Fontana
Keywords
clinician
complex case
liver injury
antibiotic treatment
idiosyncratic drug-induced liver injury
precision medicine
×
Please select your language
1
English